Short Interest in American Oncology Network, Inc. (NASDAQ:AONC) Declines By 32.7%

American Oncology Network, Inc. (NASDAQ:AONC) was the recipient of a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 20,400 shares, a decline of 32.7% from the February 29th total of 30,300 shares. Based on an average daily volume of 9,500 shares, the short-interest ratio is presently 2.1 days. Approximately 0.8% of the shares of the stock are short sold.

Institutional Trading of American Oncology Network

A hedge fund recently bought a new stake in American Oncology Network stock. Applied Capital LLC acquired a new stake in American Oncology Network, Inc. (NASDAQ:AONC) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 37,499 shares of the company’s stock, valued at approximately $221,000.

American Oncology Network Price Performance

AONC opened at $5.49 on Friday. The business has a 50-day moving average price of $5.76. American Oncology Network has a 12-month low of $4.78 and a 12-month high of $39.60.

American Oncology Network Company Profile

American Oncology Network, Inc, through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance.